Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder

Objectives: Adult attention-deficit/hyperactivity disorder (ADHD) is an important mental health problem that needs resolution, especially considering the high rates of ADHD continuation from childhood to adolescence/adulthood and the high prevalence of ADHD in adults. Adults with ADHD have lifelong negative impacts and require close monitoring with long-term follow-up. Hence, the establishment of a Korean practice parameter for adult ADHD is necessary to minimize discontinuation of treatment and enable information sharing among Korean mental health professionals. Methods: The Korean practice parameter was developed using an evidence-based approach consisting of expert consensus survey coupled with literature review. Results: According to the expert consensus survey, the most commonly used diagnostic methods were clinical psychiatric interview (20.66%) and self-report scales (19.25%) followed by attention (14.71%) and psychological tests (14.24%). Key evaluation instruments currently available in Korea are the World Health Organization Adult ADHD Self-Report Rating Scale, Korean Adult ADHD Rating Scale, Diagnostic Interview for ADHD in Adults, Barkley Deficits in Executive Functioning Scale for adults, Comprehensive Attention Test, Conners’ Continuous Performance Test, and the subtests of Wechsler Adult Intelligence Scale, Digit Span and Letter-Number Sequencing. Although pharmacotherapy is recommended as the first-line of treatment for adult ADHD, we recommend that it be followed by a multimodal and multidisciplinary approach including psychoeducation, pharmacotherapy, cognitive behavior therapy and coaching. Conclusion: The Korean practice parameter introduces not only general information for the diagnosis and treatment of adult ADHD on a global scale, but also the process of diagnosis and treatment options tailored to the Korean population.

[1]  M. Weiser,et al.  Functioning of Young Adults With ADHD in the Military , 2019, Journal of attention disorders.

[2]  D. Han,et al.  Clinical Utility and Cut-Off Scores of the Korean Adult Attention-Deficit/Hyperactivity Disorder Rating Scale , 2019, Soa--ch'ongsonyon chongsin uihak = Journal of child & adolescent psychiatry.

[3]  D. Han,et al.  Comparison of Attention-Deficit/Hyperactivity Disorder Practice in Adults According to a Training Background in Child Psychiatry , 2019, Soa--ch'ongsonyon chongsin uihak = Journal of child & adolescent psychiatry.

[4]  Ivanei E. Bramati,et al.  Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. , 2019, The American journal of psychiatry.

[5]  H. Yoo,et al.  Developmental Trajectories of Attention in Normal Korean Population , 2019, Soa--ch'ongsonyon chongsin uihak = Journal of child & adolescent psychiatry.

[6]  G. Bahn,et al.  Social function of adult men with attention-deficit/hyperactivity disorder in the context of military service , 2018, Neuropsychiatric disease and treatment.

[7]  E Sobanski,et al.  Updated European Consensus Statement on diagnosis and treatment of adult ADHD , 2018, European Psychiatry.

[8]  B. Franke,et al.  Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan , 2018, European Neuropsychopharmacology.

[9]  I. Hwang,et al.  Genetic associations between ADHD and dopaminergic genes (DAT1 and DRD4) VNTRs in Korean children , 2018, Genes & Genomics.

[10]  F. Castellanos,et al.  Predicting the Adult Functional Outcomes of Boys With ADHD 33 Years Later. , 2018, Journal of the American Academy of Child and Adolescent Psychiatry.

[11]  A. Koyanagi,et al.  Attention‐deficit/hyperactivity disorder symptoms and suicidal behavior in adult psychiatric outpatients , 2018, Psychiatry and clinical neurosciences.

[12]  P. Asherson,et al.  Emotion dysregulation in attention-deficit/hyperactivity disorder and borderline personality disorder , 2018, Borderline Personality Disorder and Emotion Dysregulation.

[13]  M. O’Donovan,et al.  Investigating late‐onset ADHD: a population cohort investigation , 2018, Journal of child psychology and psychiatry, and allied disciplines.

[14]  M. Pompili,et al.  Suicide risk in attention-deficit/hyperactivity disorder. , 2018, Psychiatria Danubina.

[15]  Soon-Ah Chang,et al.  Clinical Utility of the Korean Version of the WHO Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale Screener , 2018, Psychiatry investigation.

[16]  F. Reimherr,et al.  ADHD and Anxiety: Clinical Significance and Treatment Implications , 2017, Current Psychiatry Reports.

[17]  Bung-Nyun Kim,et al.  Interaction between DRD2 and lead exposure on the cortical thickness of the frontal lobe in youth with attention-deficit/hyperactivity disorder , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[18]  M. Liebrenz,et al.  Skills and compensation strategies in adult ADHD – A qualitative study , 2017, PloS one.

[19]  P. Chokka,et al.  Adult ADHD and comorbid disorders: clinical implications of a dimensional approach , 2017, BMC Psychiatry.

[20]  Z. Lv,et al.  The association between attention deficit/hyperactivity disorder and internet addiction: a systematic review and meta-analysis , 2017, BMC Psychiatry.

[21]  Elizabeth B. Owens,et al.  Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity , 2017, Journal of child psychology and psychiatry, and allied disciplines.

[22]  Cynthia Rudin,et al.  The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5 , 2017, JAMA psychiatry.

[23]  Maria Panagiotidi,et al.  Problematic Video Game Play and ADHD Traits in an Adult Population , 2017, Cyberpsychology Behav. Soc. Netw..

[24]  D. Galland,et al.  Implications du trouble déficitaire de l’attention en psychiatrie légale : revue de littérature systématique , 2017 .

[25]  Alan M. Zaslavsky,et al.  The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys , 2017, ADHD Attention Deficit and Hyperactivity Disorders.

[26]  H. Holling,et al.  Long-Term Memory Performance in Adult ADHD , 2017, Journal of attention disorders.

[27]  L. Weyandt,et al.  Neuropsychological Functioning in College Students With and Without ADHD , 2017, Neuropsychology.

[28]  L. Thorell,et al.  Neuropsychological Functioning in Adults With ADHD and Adults With Other Psychiatric Disorders , 2017, Journal of attention disorders.

[29]  Jun Won Kim,et al.  The Guideline of Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder: Developed by ADHD Translational Research Center , 2016 .

[30]  F. Serre,et al.  Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions , 2016, Psychiatry Research.

[31]  P. Lichtenstein,et al.  Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study , 2016, Biological Psychiatry.

[32]  V. Balanzá-Martínez,et al.  Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD , 2016, Journal of attention disorders.

[33]  John T. Mitchell,et al.  Method of adult diagnosis influences estimated persistence of childhood ADHD: a systematic review of longitudinal studies. , 2016, The lancet. Psychiatry.

[34]  R. Tannock,et al.  Symptom Manifestation and Impairments in College Students With ADHD , 2016, Journal of learning disabilities.

[35]  T. Moffitt,et al.  Life Span Studies of ADHD—Conceptual Challenges and Predictors of Persistence and Outcome , 2016, Current Psychiatry Reports.

[36]  G. Gudjonsson,et al.  A randomized controlled trial reporting functional outcomes of cognitive–behavioural therapy in medication-treated adults with ADHD and comorbid psychopathology , 2016, European Archives of Psychiatry and Clinical Neuroscience.

[37]  A. London,et al.  Attention Deficit Hyperactivity Disorder and adult mortality. , 2016, Preventive medicine.

[38]  D. Bijlenga,et al.  ADHD in old age: a review of the literature and proposal for assessment and treatment , 2016, Expert review of neurotherapeutics.

[39]  I. Manor,et al.  New DSM-5 criteria for ADHD - Does it matter? , 2016, Comprehensive psychiatry.

[40]  J. Swanson,et al.  Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome. , 2016, JAMA psychiatry.

[41]  A. Danese,et al.  Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood. , 2016, JAMA psychiatry.

[42]  Hyejung Chang,et al.  The Diagnostic Distribution of Psychiatric Disorders among the Population Under 19 Years Old: Based on the National Insurance Data , 2016 .

[43]  W. Retz,et al.  The intraindividual impact of ADHD on the transition of adulthood to old age , 2016, European Archives of Psychiatry and Clinical Neuroscience.

[44]  E. Roughead,et al.  Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study , 2016, British Medical Journal.

[45]  김지혜,et al.  한국어판 바클리 집행기능결핍척도의 신뢰도 및 타당도 연구 , 2016 .

[46]  G. Zalsman,et al.  Adult ADHD: A new disease? , 2016, International journal of psychiatry in clinical practice.

[47]  R. Stieglitz,et al.  Emotional symptoms and their contribution to functional impairment in adults with attention-deficit/hyperactivity disorder , 2016, ADHD Attention Deficit and Hyperactivity Disorders.

[48]  Joel L. Young,et al.  Supplementary guanfacine hydrochloride as a treatment of attention deficit hyperactivity disorder in adults: A double blind, placebo-controlled study , 2016, Psychiatry Research.

[49]  K. Jørgensen,et al.  Cognitive behavioural therapy for ADHD in adults: systematic review and meta-analyses , 2016, ADHD Attention Deficit and Hyperactivity Disorders.

[50]  D. Han,et al.  Development of Korean Adult ADHD Rating Scale , 2015 .

[51]  M. Abdel-Hamid,et al.  Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. , 2015, JAMA psychiatry.

[52]  A. Ludolph,et al.  Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe , 2015, Clinical Drug Investigation.

[53]  Jan K. Buitelaar,et al.  Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements , 2015, European Neuropsychopharmacology.

[54]  R. Kuja‐Halkola,et al.  Heritability of attention‐deficit hyperactivity disorder in adults , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[55]  E. Viding,et al.  Genetic and Environmental Influences on the Developmental Course of Attention-Deficit/Hyperactivity Disorder Symptoms From Childhood to Adolescence. , 2015, JAMA psychiatry.

[56]  S. Dalsgaard,et al.  Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study , 2015, The Lancet.

[57]  D. Belsky,et al.  Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study. , 2015, The American journal of psychiatry.

[58]  A. Ghanizadeh A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder , 2015, Nordic journal of psychiatry.

[59]  J. Martínez-Raga,et al.  Attention-deficit hyperactivity disorder (ADHD), substance use disorders, and criminality: a difficult problem with complex solutions , 2015, International journal of adolescent medicine and health.

[60]  C. Kieling,et al.  Cadherin‐13 gene is associated with hyperactive/impulsive symptoms in attention/deficit hyperactivity disorder , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[61]  Young-Eun Jung,et al.  Prevalence and correlates of attention-deficit hyperactivity disorder symptoms in Korean college students , 2015, Neuropsychiatric disease and treatment.

[62]  H. Caci,et al.  Effect of Treatment Modality on Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder: A Systematic Review , 2015, PloS one.

[63]  T. Cummins,et al.  The molecular genetic architecture of attention deficit hyperactivity disorder , 2015, Molecular Psychiatry.

[64]  Donna B. Pincus,et al.  Inattention symptoms and the diagnosis of comorbid attention-deficit/hyperactivity disorder among youth with generalized anxiety disorder. , 2014, Journal of anxiety disorders.

[65]  R. Tremblay,et al.  The developmental course of childhood inattention symptoms uniquely predicts educational attainment: A 16-year longitudinal study , 2014, Psychiatry Research.

[66]  M. Pennick,et al.  Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells , 2014, Neuropsychiatric disease and treatment.

[67]  J. Ramos-Quiroga,et al.  The Conners’ Adult ADHD Rating Scales—Short Self-Report and Observer Forms , 2014, Journal of attention disorders.

[68]  Yun-Chul Hong,et al.  Environmental Lead Exposure and Attention Deficit/Hyperactivity Disorder Symptom Domains in a Community Sample of South Korean School-Age Children , 2014, Environmental health perspectives.

[69]  M. Srisurapanont,et al.  Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD , 2014, Drug design, development and therapy.

[70]  X. Castells,et al.  Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents. , 2014, The Cochrane database of systematic reviews.

[71]  R. Findling,et al.  Comorbidities in Adult Attention-Deficit/Hyperactivity Disorder: A Practical Guide to Diagnosis in Primary Care , 2014, Postgraduate medicine.

[72]  N. Maneeton,et al.  A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder , 2014, Neuropsychiatric disease and treatment.

[73]  P. Lichtenstein,et al.  Stimulant ADHD medication and risk for substance abuse. , 2014, Journal of child psychology and psychiatry, and allied disciplines.

[74]  A. Young,et al.  Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults , 2014, Current medical research and opinion.

[75]  G. Salum,et al.  ADHD in DSM-5: a field trial in a large, representative sample of 18- to 19-year-old adults , 2014, Psychological Medicine.

[76]  A. Sjölander,et al.  Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study , 2014, BMJ : British Medical Journal.

[77]  Bung-Nyun Kim,et al.  Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD) , 2014, Behavioral and Brain Functions.

[78]  D. Coghill,et al.  A Systematic Review of the Safety of Lisdexamfetamine Dimesylate , 2014, CNS Drugs.

[79]  J. Ramos-Quiroga,et al.  Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults , 2014, Expert review of neurotherapeutics.

[80]  A. Philipsen,et al.  Common ground in Attention Deficit Hyperactivity Disorder (ADHD) and Borderline Personality Disorder (BPD)–review of recent findings , 2014, Borderline Personality Disorder and Emotion Dysregulation.

[81]  A. Sjölander,et al.  Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. , 2014, JAMA psychiatry.

[82]  Ellen Leibenluft,et al.  Emotion dysregulation in attention deficit hyperactivity disorder. , 2014, The American journal of psychiatry.

[83]  D. Nutt,et al.  Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology , 2014, Journal of psychopharmacology.

[84]  M. Bayés,et al.  Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder. , 2014, Journal of psychiatric research.

[85]  L. Adler,et al.  A 9-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD , 2014, Journal of attention disorders.

[86]  J. Swanson,et al.  Clinical practice: Adult attention deficit-hyperactivity disorder. , 2013, The New England journal of medicine.

[87]  T. Banaschewski,et al.  Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies , 2013, BMC Psychiatry.

[88]  R. Cunill,et al.  Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta‐analysis and meta‐regression , 2013, Pharmacoepidemiology and drug safety.

[89]  L. Adler,et al.  Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. , 2013, The Journal of clinical psychiatry.

[90]  J. Ramos-Quiroga,et al.  Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines , 2013, Current medical research and opinion.

[91]  K. Lesch,et al.  Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHD , 2013, European Neuropsychopharmacology.

[92]  D. McManus,et al.  Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults , 2013, European Neuropsychopharmacology.

[93]  R. Robison,et al.  Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale. , 2013, Psychological assessment.

[94]  P. Asherson,et al.  Emotional lability, comorbidity and impairment in adults with attention-deficit hyperactivity disorder. , 2013, Journal of affective disorders.

[95]  P. Hodgkins,et al.  Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis , 2013, Journal of medical economics.

[96]  Anthony Liu,et al.  Medication for attention deficit-hyperactivity disorder and criminality. , 2013, The New England journal of medicine.

[97]  S. Faraone,et al.  Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study , 2013, ADHD Attention Deficit and Hyperactivity Disorders.

[98]  Ji-Hae Kim,et al.  The WHO Adult ADHD Self-Report Scale: Reliability and Validity of the Korean Version , 2013, Psychiatry investigation.

[99]  J. Brook,et al.  Adolescent ADHD and Adult Physical and Mental Health, Work Performance, and Financial Stress , 2013, Pediatrics.

[100]  A. Sjölander,et al.  Medication for attention deficit-hyperactivity disorder and criminality. , 2012, The New England journal of medicine.

[101]  A. Philipsen Psychotherapy in adult attention deficit hyperactivity disorder: implications for treatment and research , 2012, Expert review of neurotherapeutics.

[102]  H. Nordahl,et al.  Functional Impairment and Occupational Outcome in Adults With ADHD , 2012, Journal of attention disorders.

[103]  R. Stieglitz,et al.  Emotional dysregulation in adult ADHD: what is the empirical evidence? , 2012, Expert review of neurotherapeutics.

[104]  P. Lichtenstein,et al.  Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large Swedish population-based study of twins , 2012, Psychological Medicine.

[105]  L. Hechtman,et al.  Cognitive Behavior Therapy for Adults with Attention-Deficit/Hyperactivity Disorder: A Review of Recent Randomized Controlled Trials , 2012, Current Psychiatry Reports.

[106]  A. Thapar,et al.  Practitioner Review: What have we learnt about the causes of ADHD? , 2013, Journal of Child Psychology and Psychiatry, and Allied Disciplines.

[107]  J. Ramos-Quiroga,et al.  The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents , 2012, International Archives of Occupational and Environmental Health.

[108]  Arthur N Westover,et al.  Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review , 2012, BMC Cardiovascular Disorders.

[109]  U. Müller,et al.  Systematic review of national and international guidelines on attention-deficit hyperactivity disorder , 2012, Journal of psychopharmacology.

[110]  B. Cha,et al.  Effect of Symptoms of Adult Attention Deficit Hyperactivity Disorder on Symptoms of Post Traumatic Stress Disorder in Korean Conscripts , 2012, Psychiatry investigation.

[111]  Rosemary Tannock,et al.  Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. , 2012, Journal of abnormal psychology.

[112]  J. Rossi,et al.  Double-Blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in College Students With ADHD , 2012, Journal of attention disorders.

[113]  I. Sigfusdottir,et al.  An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. , 2012, Journal of child psychology and psychiatry, and allied disciplines.

[114]  Karenleigh A. Overmann,et al.  Prevalence of ADHD and its subtypes in male and female adult prison inmates. , 2012, Behavioral sciences & the law.

[115]  W. Bilker,et al.  Methylphenidate and risk of serious cardiovascular events in adults. , 2012, The American journal of psychiatry.

[116]  R. Barkley,et al.  Lifespan persistence of ADHD: the life transition model and its application. , 2012, The Journal of clinical psychiatry.

[117]  Bruce H Fireman,et al.  ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. , 2011, JAMA.

[118]  R. Tremblay,et al.  Childhood trajectories of inattention and hyperactivity and prediction of educational attainment in early adulthood: a 16-year longitudinal population-based study. , 2011, The American journal of psychiatry.

[119]  R. Kesner,et al.  An analysis of rat prefrontal cortex in mediating executive function , 2011, Neurobiology of Learning and Memory.

[120]  L. Kiemeney,et al.  DIRAS2 is Associated with Adult ADHD, Related Traits, and Co-Morbid Disorders , 2011, Neuropsychopharmacology.

[121]  P. Lichtenstein,et al.  Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology. , 2011, Journal of child psychology and psychiatry, and allied disciplines.

[122]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[123]  A. Arnsten,et al.  Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders , 2011, Pharmacology Biochemistry and Behavior.

[124]  S. Segal,et al.  Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD , 2011, Pediatrics.

[125]  S. Faraone,et al.  Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis. , 2011, The American journal of psychiatry.

[126]  Fassnacht,et al.  Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree , 2011, Molecular Psychiatry.

[127]  H. Jeon,et al.  Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: Results of the Korean epidemiologic catchment area study , 2011, Psychiatry Research.

[128]  D. Huse,et al.  Risk of injury associated with attention-deficit/hyperactivity disorder in adults enrolled in employer-sponsored health plans: a retrospective analysis. , 2011, The primary care companion for CNS disorders.

[129]  T. Hirvikoski,et al.  Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. , 2011, Behaviour research and therapy.

[130]  S. Segal,et al.  Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. , 2011, Journal of the American Academy of Child and Adolescent Psychiatry.

[131]  David Rigau,et al.  Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder , 2011, CNS drugs.

[132]  R. Barkley,et al.  The Nature of Executive Function (EF) Deficits in Daily Life Activities in Adults with ADHD and Their Relationship to Performance on EF Tests , 2011 .

[133]  C. Freitag,et al.  A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. , 2010, Molecular psychiatry.

[134]  M. Tehrani-Doost,et al.  Efficacy of reboxetine in adults with attention‐deficit/hyperactivity disorder: A randomized, placebo‐controlled clinical trial , 2010, Human psychopharmacology.

[135]  R. Kessler,et al.  Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. , 2010, Archives of general psychiatry.

[136]  Michael Fitzgerald,et al.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD , 2010, BMC psychiatry.

[137]  R. Barkley Why Emotional Impulsiveness Should Be a Central Feature of ADHD , 2010 .

[138]  J. Hebebrand,et al.  German Validation of the Conners Adult ADHD Rating Scales–self-report (CAARS-S) I: Factor Structure and Normative Data , 2010, European Psychiatry.

[139]  P. Chokka,et al.  Adult ADHD and its comorbidities, with a focus on bipolar disorder. , 2010, Journal of affective disorders.

[140]  T. Wigal,et al.  Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design , 2010, Behavioral and Brain Functions.

[141]  S. Faraone,et al.  A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. , 2010, The Journal of clinical psychiatry.

[142]  G. Willemsen,et al.  Genetic Epidemiology of Attention Deficit Hyperactivity Disorder (ADHD Index) in Adults , 2010, PloS one.

[143]  S. Faraone,et al.  Molecular genetics of attention deficit hyperactivity disorder. , 2010, The Psychiatric clinics of North America.

[144]  J. Norvilitis,et al.  ADHD Symptomatology and Its Relationship to Factors Associated With College Adjustment , 2009, Journal of attention disorders.

[145]  A. Palmini,et al.  Attention deficit hyperactivity disorder and the behavior of “Che” Guevara , 2009, Journal of Clinical Neuroscience.

[146]  F Curtis Breslin,et al.  Work injury risk among young people with learning disabilities and attention-deficit/hyperactivity disorder in Canada. , 2009, American journal of public health.

[147]  L. Weyandt,et al.  College Students With ADHD , 2009, Journal of attention disorders.

[148]  Jung-Woo Son,et al.  Standardization of the Comprehensive Attention Test for the Korean Children and Adolescents. , 2009 .

[149]  Benjamin M. Neale,et al.  Genome-wide association studies in ADHD , 2009, Human Genetics.

[150]  C. Gillberg,et al.  Occupational Outcome in Adult ADHD: Impact of Symptom Profile, Comorbid Psychiatric Problems, and Treatment , 2009, Journal of attention disorders.

[151]  William Kronenberger,et al.  Atomoxetine treatment in adults with attention‐deficit/hyperactivity disorder and comorbid social anxiety disorder , 2009, Depression and anxiety.

[152]  S. Bálint,et al.  Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis , 2009, British Journal of Psychiatry.

[153]  C. Kratochvil,et al.  Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder , 2009 .

[154]  D. Kang,et al.  Shorter dinucleotide repeat length in the DRD5 gene is associated with attention deficit hyperactivity disorder. , 2009, Psychiatric genetics.

[155]  B. Johansson,et al.  Old people reporting childhood AD/HD symptoms: Retrospectively self-rated AD/HD symptoms in a population-based Swedish sample aged 65–80 , 2009, Nordic journal of psychiatry.

[156]  Aribert Rothenberger,et al.  Genome‐wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[157]  B. Franke,et al.  Meta‐analysis of genome‐wide linkage scans of attention deficit hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[158]  M. Daly,et al.  Genome‐wide association scan of the time to onset of attention deficit hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[159]  M. Fitzgerald Adult deficit hyperactivity disorder and other diagnosis , 2008, Irish Journal of Psychological Medicine.

[160]  R. Barkley,et al.  Unrecognized Attention-Deficit/Hyperactivity Disorder in Adults Presenting with Other Psychiatric Disorders , 2008, CNS Spectrums.

[161]  Ann-Christine Ehlis,et al.  Reduced lateral prefrontal activation in adult patients with attention-deficit/hyperactivity disorder (ADHD) during a working memory task: a functional near-infrared spectroscopy (fNIRS) study. , 2008, Journal of psychiatric research.

[162]  R. Klein,et al.  Lifetime criminality among boys with attention deficit hyperactivity disorder: A prospective follow-up study into adulthood using official arrest records , 2008, Psychiatry Research.

[163]  J. Biederman,et al.  Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. , 2008, The Journal of clinical psychiatry.

[164]  J Ormel,et al.  The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative , 2008, Occupational and Environmental Medicine.

[165]  J. Buitelaar,et al.  A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder , 2008, Biological Psychiatry.

[166]  R. Plomin,et al.  Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. , 2008, Journal of child psychology and psychiatry, and allied disciplines.

[167]  L. Hechtman,et al.  Research Forum on Psychological Treatment of Adults With ADHD , 2008, Journal of attention disorders.

[168]  B. Biswal,et al.  Cingulate-Precuneus Interactions: A New Locus of Dysfunction in Adult Attention-Deficit/Hyperactivity Disorder , 2008, Biological Psychiatry.

[169]  W. Pelham,et al.  Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[170]  N. Laird,et al.  Family‐based association analysis of a statistically derived quantitative traits for ADHD reveal an association in DRD4 with inattentive symptoms in ADHD individuals , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[171]  Alan C. Evans,et al.  Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation , 2007, Proceedings of the National Academy of Sciences.

[172]  C. McDougle,et al.  Guanfacine and guanfacine extended release: treatment for ADHD and related disorders. , 2007, CNS drug reviews.

[173]  S. Rauch,et al.  Further Evidence of Dopamine Transporter Dysregulation in ADHD: A Controlled PET Imaging Study Using Altropane , 2007, Biological Psychiatry.

[174]  Shuhong Zhao,et al.  Candidate Gene Identification Approach: Progress and Challenges , 2007, International journal of biological sciences.

[175]  M. Weiss,et al.  Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults , 2007, Current psychiatry reports.

[176]  T. Spencer,et al.  Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. , 2007, Journal of child and adolescent psychopharmacology.

[177]  B. Pennington,et al.  Understanding comorbidity: A twin study of reading disability and attention‐deficit/hyperactivity disorder , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[178]  E. Grevet,et al.  Serotonin transporter gene polymorphism and the phenotypic heterogeneity of adult ADHD , 2007, Journal of Neural Transmission.

[179]  L. Rohde,et al.  Epidemiology of attention-deficit/hyperactivity disorder across the lifespan , 2007, Current opinion in psychiatry.

[180]  W. Canu,et al.  Rejection Sensitivity and Social Outcomes of Young Adult Men With ADHD , 2007, Journal of attention disorders.

[181]  Marley W. Watkins,et al.  ADHD and Achievement , 2007, Journal of learning disabilities.

[182]  A. Rostain,et al.  Issues in ADHD in Adults , 2006 .

[183]  P. Herzberg,et al.  Diagnostic instruments , 2006, Psycho-social medicine.

[184]  B. Molina,et al.  Childhood ADHD Predicts Risky Sexual Behavior in Young Adulthood , 2006, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[185]  E. Sobanski Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD) , 2006, European Archives of Psychiatry and Clinical Neuroscience.

[186]  J. Buitelaar,et al.  Long-acting medications for the hyperkinetic disorders , 2006, European Child & Adolescent Psychiatry.

[187]  L. Hechtman,et al.  A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. , 2006, The Journal of clinical psychiatry.

[188]  R. Kessler,et al.  The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. , 2006, The American journal of psychiatry.

[189]  R. Barkley,et al.  Young adult outcome of hyperactive children: adaptive functioning in major life activities. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[190]  S. Sandberg the biopsychosocial context of adhd , 2005 .

[191]  Joseph Biederman,et al.  Attention-Deficit/Hyperactivity Disorder: A Selective Overview , 2005, Biological Psychiatry.

[192]  G. Bush,et al.  Functional Neuroimaging of Attention-Deficit/Hyperactivity Disorder: A Review and Suggested Future Directions , 2005, Biological Psychiatry.

[193]  V. Russell,et al.  A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. , 2005, The Behavioral and brain sciences.

[194]  Joseph Biederman,et al.  The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies , 2005, Psychological Medicine.

[195]  J. Wasserstein,et al.  Diagnostic issues for adolescents and adults with ADHD. , 2005, Journal of clinical psychology.

[196]  Olga V. Demler,et al.  The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population , 2005, Psychological Medicine.

[197]  V. Harpin,et al.  The effect of ADHD on the life of an individual, their family, and community from preschool to adult life , 2005, Archives of Disease in Childhood.

[198]  H. Birnbaum,et al.  Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. , 2004, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[199]  L. Hechtman,et al.  The marital and family functioning of adults with ADHD and their spouses , 2004, Journal of attention disorders.

[200]  J. Buitelaar,et al.  Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial , 2004, Psychological Medicine.

[201]  L. Adler,et al.  Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. , 2004, The Psychiatric clinics of North America.

[202]  S. Young The YAQ-S and YAQ-I: the development of self and informant questionnaires reporting on current adult ADHD symptomatology, comorbid and associated problems , 2004 .

[203]  L. Adler Clinical presentations of adult patients with ADHD. , 2004, The Journal of clinical psychiatry.

[204]  Simon E Fisher,et al.  Familial and genetic effects on motor coordination, laterality, and reading-related cognition. , 2003, The American journal of psychiatry.

[205]  P. Hazell,et al.  A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[206]  L. Hechtman,et al.  The psychosocial functioning of children and spouses of adults with ADHD. , 2003, Journal of child psychology and psychiatry, and allied disciplines.

[207]  K. Macey Conners' Adult ADHD Rating Scales (CAARS). , 2003 .

[208]  R. Bakeman,et al.  Concordance of self- and informant ratings of adults' current and childhood attention-deficit/hyperactivity disorder symptoms. , 2002, Psychological assessment.

[209]  A. Robin,et al.  The Impact of ADHD on Marriage , 2002 .

[210]  M. Monuteaux,et al.  Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? , 2000, Journal of consulting and clinical psychology.

[211]  R. Schachar,et al.  Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. , 2000, The American journal of psychiatry.

[212]  S. Faraone,et al.  Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. , 2000, The American journal of psychiatry.

[213]  I. Waldman,et al.  Sex differences in genetic and environmental influences on DSM-III-R attention-deficit/hyperactivity disorder. , 1999, Journal of abnormal psychology.

[214]  S. Faraone,et al.  Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[215]  E. Rossini,et al.  Retrospective Self-Reported Symptoms of Attention-Deficit Hyperactivity Disorder: Reliability of the Wender Utah Rating Scale , 1995, Psychological reports.

[216]  S. Faraone,et al.  Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. , 1995, The American journal of psychiatry.

[217]  S. Faraone,et al.  High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. , 1995, The American journal of psychiatry.

[218]  R. Barkley,et al.  Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment , 1994 .

[219]  Judith M. Rumsey,et al.  Cerebral glucose metabolism in adults with hyperactivity of childhood onset. , 1990 .

[220]  A. Deister,et al.  [Attention-deficit/hyperactivity disorder (ADHD) in adult psychiatry: Data on 12-month prevalence, risk factors and comorbidity]. , 2019, Fortschritte der Neurologie-Psychiatrie.

[221]  L. Notardonato,et al.  ["Attention deficit hyperactivity disorder in forensic psychiatry: A review"]. , 2017, L'Encephale.

[222]  S. Akhondzadeh,et al.  Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind study. , 2014, Acta medica Iranica.

[223]  F. Petermann,et al.  [Adult ADHD versus borderline personality disorder: criteria for differential diagnosis]. , 2014, Fortschritte der Neurologie-Psychiatrie.

[224]  T. Epstein,et al.  Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. , 2014, The Cochrane database of systematic reviews.

[225]  G. Willemsen,et al.  Genetic and environmental stability in attention problems across the lifespan: evidence from the Netherlands twin register. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

[226]  Richard E. Tremblay,et al.  KmL3D: A non-parametric algorithm for clustering joint trajectories , 2013, Comput. Methods Programs Biomed..

[227]  J. Martínez-Raga,et al.  Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder , 2012, CNS Drugs.

[228]  Tova Rosenbloom,et al.  Thirty-day self-reported risky driving behaviors of ADHD and non-ADHD drivers. , 2011, Accident; analysis and prevention.

[229]  J. Naglieri,et al.  Encyclopedia of child behavior and development , 2011 .

[230]  A. Philipsen,et al.  KAPITEL 7 – Coaching , 2008 .

[231]  D. Cox,et al.  A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. , 2007, Journal of safety research.

[232]  M. Willoughby Developmental course of ADHD symptomatology during the transition from childhood to adolescence: a review with recommendations. , 2003, Journal of child psychology and psychiatry, and allied disciplines.

[233]  J. Biederman,et al.  A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. , 2000, Journal of child and adolescent psychopharmacology.

[234]  T. Brown Attention-deficit disorders and comorbidities in children, adolescents, and adults , 2000 .

[235]  Kevin R. Murphy,et al.  Attention-deficit hyperactivity disorder: A clinical workbook, 2nd ed. , 1998 .

[236]  Kevin R. Murphy,et al.  Attention-deficit hyperactivity disorder : a clinical workbook , 1991 .